Who invested in ROME Therapeutics?
ROME Therapeutics's investors include Andreessen Horowitz, Google Ventures, ARCH Venture Partners, Alexandria Venture Investments and Sanofi, and 1 more on record.
United States · Series B startup
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow ROME Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$72Mraised across 1 round since 2023, from 1 source
Source recorded
ROME Therapeutics's investors include Andreessen Horowitz, Google Ventures, ARCH Venture Partners, Alexandria Venture Investments and Sanofi, and 1 more on record.
ROME Therapeutics has raised $72M across 1 round since 2023.
ROME Therapeutics's most recent round was a Series B of $72M in Sept 2023.
Its most recent round, $72M in Sept 2023, is also its largest on record.
ROME Therapeutics's first round on record, in Sept 2023, was backed by Andreessen Horowitz, Google Ventures and ARCH Venture Partners and 3 others.
ROME Therapeutics's latest named round is a Series B, in Sept 2023.
ROME Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.